
Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
Lena Mueller is the head of functional excipients for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.

Published: October 7th 2022 | Updated: